BD Intraosseous Needle Kit Recall Issued Over Risk of Serious Injury or Death

The BD Intraosseous Needle Kit recall follows nearly 40 complaints of problems

Following dozens of complaints involving problems with intraosseous needle kits, Becton Dickinson has recalled thousands of drills and tens of thousands of needle sets used to access blood vessels in patients’ bones being removed from the market.

The FDA announced the BD Intraosseous Needle and Driver Kit recall on August 11, giving it a Class I designation, which suggests that continued use of the product may pose a risk of serious injury or death.

Becton Dickinson first reported problems with the kits in June, after identifying at least 37 complaints reported. However, the manufacturer maintains that no injuries or deaths have been reported in relation to the recalled needle kits.

Problem with BD Intraosseous Needle Kits

BD intraosseous needle kits and powered drivers are used by doctors to gain access to blood vessels through a patient’s bone when emergency, urgent, or medically necessary care is needed. It is done when it is difficult or impossible for the doctor to obtain typical access through the blood vessels, requiring them to enter through bone (intraosseous).

Intraosseous access is most often used in critically ill patients, including those with cardiopulmonary arrest or severe shock. This recall can lead to potential delays in care that can cause serious injury or death to critically ill patients. It also poses a risk of needle stick injury.

The recall was initiated due to three separate issues. First, the stylet may be difficult to separate from the needle or may not separate at all. This can lead to inadvertent removal of the entire needle assembly during placement, or the doctor may be unable to remove the stylet from the needle, leading to loss of intraosseous access or function loss.

Second, the needle safety mechanism may not properly deploy as the stylet is removed from the intraosseous needle after placement. Third, metal discs may stick in the powered driver, which may render it unusable.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

The recall impacts Becton Dickinson Intraosseous Needle Set Kits, Intraosseous Powered Driver Kits, and Intraosseous Powered Drivers distributed between January 20, 2020, to May 5, 2022. An estimated 2,207 drills and 34,355 needle sets are affected.

Becton Dickinson sent an urgent medical device recall letter to customers on June 20, calling for customers with affected devices to quarantine them, destroy affected needle kits, and urging them not to use affected powered drivers until a Sales Representative can determine they are safe to use.

The manufacturer also called for customers to share recall information with other users. Becton Dickinson also warns that there are no replacements for these products at this time and urged customers to obtain and use an alternative intraosseous product.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Uber Driver Sexual Assaults and Misconduct Reports Must Be Disclosed in Lawsuit Discovery
Uber Driver Sexual Assaults and Misconduct Reports Must Be Disclosed in Lawsuit Discovery (Posted today)

A federal magistrate judge is forcing Uber to hand over potentially hundreds of thousands of incident files involving reports of passengers who suffered sexual misconduct or sexual assault at the hands of the rideshare service's drivers.

Abbott May Remove Infant Formula for Preemies Off the Market Due to Similac NEC Lawsuits
Abbott May Remove Infant Formula for Preemies Off the Market Due to Similac NEC Lawsuits (Posted yesterday)

Abbott Laboratories is considering removing Similac infant formula products designed for preterm babies from the market, as it faces hundreds of lawsuits claiming the products increase the risk of necrotizing enterocolitis, which puts newborns at a high risk of permanent injuries and death.

Information About Suboxone Dental Claims To Be Exchanged By Parties in MDL
Information About Suboxone Dental Claims To Be Exchanged By Parties in MDL (Posted 2 days ago)

A federal judge has ordered parties involved in Suboxone dental decay lawsuits to submit proposals for exchanging information that will guide the selection of representative bellwether claims for early test trials.